Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register

View/Open
Influence_of_co_morbid_fibromyalgia_on_disease_activity_measures_and_response_to_tumour_necrosis_factor_inhibitors_in_axial_spondyloarthritis_results_from_a_UK_national_register.pdf (212.9Kb)
Publication date
01/11/2018
Author
Metadata
Show full item record
Citation
Macfarlane , G J , MacDonald , R I R , Pathan , E , Siebert , S , Gaffney , K , Choy , E , Packham , J , Martin , K R , Haywood , K , Sengupta , R , Atzeni , F & Jones , G T 2018 , ' Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register ' , Rheumatology , vol. 57 , no. 11 , pp. 1982-1990 . https://doi.org/10.1093/rheumatology/key206
URI
http://hdl.handle.net/2164/10790
DOI
https://doi.org/10.1093/rheumatology/key206
Rights
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Collections